Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England-Reference-Cited by-同舟云学术

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England

Published:2023-07 Issue:1 Volume:87 Page:e8-e11
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Abdul Aziz Nurin,Nash Sophie Grace,Zaidi Asad^ORCID,Nyberg Tommy^ORCID,Groves Natalie,Hope Russell^ORCID,Lopez Bernal Jamie,Dabrera Gavin^ORCID,Thelwall Simon^ORCID

Funder

UK Research and Innovation

UKRI Medical Research Council

GlaxoSmithKline

Public Health England

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Kang SW, Park H, Kim JY, Lim SY, Lee S, Bae JY, et al. Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: a prospective cohort study. J Infect [Internet]; 2023 Jan 16 [cited 2023 Mar 3]. Available from: 〈https://www.journalofinfection.com/article/S0163-4453(23)00020-8/fulltext〉.

2. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5;Wang;Nature,2022

3. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations;Phua;Lancet Respir Med,2020

4. Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Boloko L, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. medRxiv; 2022, 2022.06.28.22276983.

5. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa;Wolter;Nat Commun,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of severity & clinical outcomes of COVID-19 with virus variants: A prospective, multicentre hospital network study;Indian Journal of Medical Research;2024

2. Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan;Journal of Infection;2023-09

3. An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants;Pathogens;2023-08-06

4. Vaccine effectiveness against hospitalisation and comparative odds of hospital admission and severe outcomes with BQ.1, CH.1.1. and XBB.1.5 in England;2023-08-05

5. Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75 and BQ.1 compared to BA.5 in England;2023-07-16